Fluticasone propionate, activum elementum Fluticasone Propionate Nasi Spray, est synthetica corticosteroides habens in nomine chemico S-(fluoromethyl)6a,9-difluoro-11β-17-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioata, 17-propionate.
Imago ex Drug Label Content
Fluticasone propionata est album off-album cum pondere hypothetico 500.6 & formula hypothetica eft C25H31F3O5S. Fere insolubile in aqua, gratis solutum in dimethyl sulfoxide et dimethylformamide, and slightly soluble in methanol and 95% ethanol.
Fluticasone Propionate Nasal Spray, 50 mcg is an aqueous suspension of microfine fluticasone propionate for topical administration to the nasal mucosa by means of a metering, atomizing spray pump. Fluticasone Propionate Nasal Spray also contains 0.02% w/w benzalkonium chloride, dextrose, microcrystalline cellulose and carboxymethylcellulose sodium, 0.25% w/w phenylethyl alcohol, and polysorbate 80 and has a pH between 5 et 7.
It is necessary to prime the pump before first use or after a period of non-use (1 week or more). After initial priming (six actuations), each actuation delivers 50 mcg of fluticasone propionate in 100 mg of formulation through the nasal adapter. Each 16-g bottle of Fluticasone Propionate Nasal Spray provides 120 metered sprays. post 120 metered sprays, moles fluticasone propionate liberata per actum non potest consistere et unitas abicienda est.
Fluticasone inhalatione pulveris vel aerosol prophylaxis asthmatis adhibetur. Typical initialis range ex paulatim in UK 100 to 250 micrograms quotidie bis leni suspirio ad 1 mg bis quotidie gravi suspiriosis, accommodetur secundum responsionem. Pueri per quattuor annos aetatis initialis dosis dari possunt 50 to 100 micrograms quotidie bis, auctus to 200 micrograms quotidie bis necessarium. Medicamentum etiam dari potest per nebuliser in asthmate gravi chronico. Solet adulta paulatim are 0.5 to 2 mg bis cotidie. Pueri annorum quattuor ad sedecim annos dari possunt 1 mg bis cotidie.
